S100B protein in carbon monoxide poisoning: a pilot study | Canada Hyperbarics Skip to main content
Prospective Study Resuscitation 2004

S100B protein in carbon monoxide poisoning: a pilot study

Brvar M, Mozina H, Osredkar J, Mozina M, Noc M, Brucan A, et al. — Resuscitation, 2004

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers measured levels of a brain protein called S100B in 38 patients with carbon monoxide poisoning to see if it could indicate brain injury.

What They Found

All three patients who were unconscious upon arrival at the emergency department had elevated S100B levels, and the patient with the highest S100B level died. Among six patients with temporary unconsciousness at the scene, two showed elevated S100B, while all 29 conscious patients had normal S100B levels.

What This Means for Canadian Patients

For Canadian patients experiencing carbon monoxide poisoning, this study suggests that S100B levels might help doctors quickly identify those with more severe brain injury. This could potentially guide treatment decisions and monitoring for those at higher risk of complications.

Canadian Relevance

This study covers carbon monoxide poisoning, which is a Health Canada-recognised indication for hyperbaric oxygen therapy.

Study Limitations

As a pilot study, the small number of participants limits the generalizability of these initial findings.

Was this summary helpful?

Study Details

Study Type Prospective Study
Category Neurological
Source Pubmed
PubMed ID 15172716
Year Published 2004
Journal Resuscitation
MeSH Terms Adolescent; Adult; Aged; Biomarkers; Carbon Monoxide Poisoning; Female; Humans; Hyperbaric Oxygenation; Hypoxia, Brain; Male; Middle Aged; Nerve Growth Factors; Pilot Projects; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Unconsciousness

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.